What is Genosource?
Founded in 2014 by experienced dairymen, GenoSource specializes in enhancing dairy profitability through advanced breeding techniques and comprehensive embryo programs. The company operates a substantial milking herd of 4,000 cows, positioning itself as a key provider of modern genetics at competitive price points. GenoSource's core mission revolves around delivering integrity and genetic advancement to foster a sustainable and lucrative future for dairy farmers.
How much funding has Genosource raised?
Genosource has raised a total of $775K across 2 funding rounds:
Debt
$350K
Debt
$425K
Debt (2020): $350K with participation from PPP
Debt (2021): $425K led by PPP
Key Investors in Genosource
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Genosource?
The substantial enterprise-level funding and recent strategic investment signal GenoSource's maturity and its capacity for further expansion and innovation. This capital infusion is likely to fuel advancements in their breeding technologies, potentially increasing herd capacity or expanding their genetic offerings. GenoSource's focus on providing high-caliber genetics at competitive prices suggests a strategy aimed at solidifying its market leadership and supporting the evolving economic landscape of the dairy sector. Future developments may include enhanced research into genetic traits for improved herd health and productivity.
See full Genosource company page
